<bill session="117" type="sr" number="792" updated="2022-12-29T13:18:31Z">
  <state datetime="2022-09-22">REFERRED</state>
  <status>
    <introduced datetime="2022-09-22"/>
  </status>
  <introduced datetime="2022-09-22"/>
  <titles>
    <title type="display">A resolution expressing support for the designation of November 2022 as "National Alpha-1 Antitrypsin Deficiency Awareness Month".</title>
    <title type="official" as="introduced">A resolution expressing support for the designation of November 2022 as "National Alpha-1 Antitrypsin Deficiency Awareness Month".</title>
  </titles>
  <sponsor bioguide_id="S001217"/>
  <cosponsors>
    <cosponsor bioguide_id="R000595" joined="2022-09-22"/>
  </cosponsors>
  <actions>
    <action datetime="2022-09-22">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2022-09-22" state="REFERRED">
      <text>Referred to the Committee on Health, Education, Labor, and Pensions.</text>
      <reference ref="CR S4973" label="text"/>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2022-11-09T20:21:23Z" status="Introduced in Senate">This resolution supports the designation of November 2022 as National Alpha-1 Antitrypsin Deficiency Awareness Month. Alpha-1 antitrypsin deficiency is a genetic disease that increases the risk of harm to the lungs, liver, skin, and blood vessels.</summary>
</bill>
